Autopsy report · NCT06200103

Schedule De-Escalation of 177Lu-PSMA-617 for the Treatment of Metastatic Castrate Resistant Prostate Cancer

“Pending additional funding.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 4 months before it started.
• Suspended: paused, and may or may not restart.
• 236 participants planned (an estimate, not an actual count).

Vital statistics

Status

Suspended

Phase

Phase 2

Sponsor

Mayo Clinic

Sponsor type

University, hospital or other

Conditions

Castration-Resistant Prostate Carcinoma; Stage IVB Prostate Cancer AJCC v8

Interventions

Biospecimen Collection; Bone Scan; Clinical Observation; Computed Tomography; Gallium Ga 68 Gozetotide; Lutetium Lu 177 Vipivotide Tetraxetan

Participants

236 (planned, not actual)

Sites

1

Countries

United States

Trials that died the same way

• Fecal Microbiota Transplantation for Patients With Chronic Widespread Pain
  “Pending for funding” (88% match in meaning)
• Natural History of Intestinal Inflammation in People With Primary Immune Dysregulations
  “Funding completed.” (78% match in meaning)
• Effect of a Smartphone Application on Oral Contraceptive Adherence in College Females
  “Funding unavailable.” (70% match in meaning)
• Smartphone-enabled Health Coaching Intervention for Youth Diagnosed With Major Depressive Disorders
  “New funding required” (68% match in meaning)
• Sex Differences in Neurobehavioral Response to THC
  “Funding status change.” (66% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.